POM-V Prescription Required

Aftopur AlSap

Active ingredient: Foot-and-mouth disease virus

Form

Injection

Species

Cattle Goats Sheep

Manufacturer

Boehringer Ingelheim Animal Health UK Ltd

VMD MA No.

08327/5002

What it's used for

For the active immunisation of ruminants to reduce clinical signs and mortality associated with Foot-and-Mouth Disease. The onset of immunity is 3 weeks (d...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Foot-and-mouth disease virus

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Aftopur AlSap — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For the active immunisation of ruminants to reduce clinical signs and mortality
associated with Foot-and-Mouth Disease.
The onset of immunity is 3 weeks (demonstrated by challenge). Immunity lasts 6
months (see section 4.9 for recommended vaccination program).

Dosages: Large ruminants 2ml; Small ruminants 1ml.
Shake before use.
The vaccine is to be administered by the Subcutaneous Route. The preferred site is
in the area of the shoulder.
Primary Vaccination :
Two injections, 3 to 4 weeks apart, starting at 2 weeks of age for young animals
from unvaccinated dams or 2.5 months of age for young animals from vaccinated
dams. In the event of an epidemic, the first injection should be given to all animals
as early as 2 weeks of age.
Boosters :
Normally, boosters should be given every 6 months, depending on the
epidemiological situation and in accordance with local legislation.

Revised: August 2021
Divergence from NI MA following 00408/2021Page 3 of 5

Do not use in unhealthy animals.

Vaccination may be followed by a small local swelling and/or slight pyrexia of short
duration. The maximum local swelling occurs 48 hours after vaccination and covers
at an extreme an average area of 24 cm
. In nearly all animals the local swelling
had disappeared within one month after vaccination.

None.

Revised: August 2021
Divergence from NI MA following 00408/2021Page 2 of 5

(i) Special precautions for use in animals
None.
(ii) Special precautions to be taken by the person administering the veterinary
medicinal product to animals
None.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. However, experience in the field suggests
that the vaccine may be used satisfactorily with a range of bacterial and viral
vaccines. A decision to use this vaccine before or after any other veterinary
medicinal product therefore needs to be made on a case by case basis.

Store and transport vaccine at 2-8
o
C. Do not freeze. Protect from light

Purified Saponin 90 HU
Excipient(s):
Chloroform, at most 6 mg/ml.
For a full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.